Molecular Basis of iNKT Cell Ontogeny and Function
Molecular Basis of iNKT Cell Ontogeny and Function
批准号:
8121825
负责人:
SEBASTIAN JOYCE
金额:
$24.27万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-08-23 至 2011-08-22
关键词:
AdjuvantAntigensApoptosisApoptoticAutoimmune DiseasesAutoimmunityBiologyCell Differentiation processCell OntogenyCell physiologyCellsCellular biologyCerebral MalariaColony-Stimulating FactorsCouplesDevelopmentDiseaseDominant-Negative MutationEmployee StrikesGalactosylceramidesGenesGlycolipidsGoalsGranulocyte-Macrophage Colony-Stimulating FactorGrowthHealthHypersensitivityImmune systemInfectionKnowledgeLeadLigationLymphocyteMediatingMolecularMusNeoplasm MetastasisNuclearPlayProcessPropertyRoleShapesSignal TransductionSpecificityT-Cell DevelopmentT-Lymphocyte SubsetsTestingTransgenic Organismsbasecell fate specificationcytokineexpectationextracellularin vivoinsightprecursor cellpreventprogramsreceptorresponsetherapeutic development
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The long-term goal of this project is to elucidate the mechanism(s) by which the invariant natural T (iNKT)
cells function in health and disease. iNKT cells are important immunoregulatory innate lymphocytes. They
mediate the adjuvant function of a-galactosylceramide (otGalCer), a CDId-restricted glycolipid antigen with
potent in vivo immunomodulatory activities against metastatic tumours, certain infections and several
autoimmune diseases. The rapid and robust cytokine response of in vivo activated iNKT cells mediates their
immunoregulatory function. Instructional processes during ontogeny determine the effector properties of
lymphocytes. Our approach to understanding iNKT cell biology has been to elucidate the intercellular and
intracellular ontogenetic signals that lead to the development and differentiation of functional iNKT cells. We
and others have recently discovered that classical nuclear factor KB (NF-kB) signalling is essential for the
maturation and function of iNKT cells but not for conventional T cell ontogeny. This function of NF-kB is
largely dependent on NFkB1 (cell autonomous), to a lesser extent on NFkB2, and RelB (cell extrinsic)
activities. Therefore, a thorough characterisation of signals that activate NF-kB and its consequences during
iNKT cell development and differentiation are essential to our understanding of iNKT cell biology. Here, we
will test the central hypothesis that NF-KB is a lineage-specific regulator, which processes and integrates
diverse extracellular signals that precisely regulate the development and differentiation of functional iNKT
cells. To test this central hypothesis, we will pursue the following three integrated yet independent specific
aims: (a) define the mechanism(s) that couples TCR signals to NF-kB activation during iNKT cell ontogeny;
(6) define the signals that induce apoptosis in iNKT cells during development; and (c) define the
mechanism(s) by which NF-kB regulates functional differentiation of iNKT cells. Upon completion of this
project, our expectationis to define the molecular mechanism(s) by which NF-kB regulates the ontogeny
and differentiation of functional iNKT cells. These findings will significantly enhance our fundamental
understanding of iNKT cell biology and will lead to deeper insights into the molecular mechanisms underlying
cell fate specification as well as molecular and functional differentiation within the immune system.
Additionally, this knowledge can lead to the development of therapeutics that either enhance (adjuvant
effect, downregulate autoimmunity) or suppress (cerebral malaria, airway hypersensitivity) iNKT cell function.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Vaccinating at Mucosal Surfaces with Nanoparticle-conjugated Antigen and Adjuvant
-
批准号:10587388
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2023
-
负责人:SEBASTIAN JOYCE
-
依托单位:
BLR&D Research Career Scientist Award Application
-
批准号:10454202
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:SEBASTIAN JOYCE
-
依托单位:
Molecular Basis of CD1D and Natural Killer T Cell Function
-
批准号:10203802
-
项目类别:
-
资助金额:$51.62万
-
财政年份:2019
-
负责人:SEBASTIAN JOYCE
-
依托单位:
BLR&D Research Career Scientist Award Application
-
批准号:9911970
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:SEBASTIAN JOYCE
-
依托单位:
Molecular Basis of CD1D and Natural Killer T Cell Function
-
批准号:10443746
-
项目类别:
-
资助金额:$51.05万
-
财政年份:2019
-
负责人:SEBASTIAN JOYCE
-
依托单位:
BLR&D Research Career Scientist Award Application
-
批准号:9766685
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:SEBASTIAN JOYCE
-
依托单位:
BLR&D Research Career Scientist Award Application
-
批准号:10265366
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:SEBASTIAN JOYCE
-
依托单位:
BLR&D Research Career Scientist Award Application
-
批准号:10618275
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:SEBASTIAN JOYCE
-
依托单位:
Head & Neck Cancer Neoantigen Characterization & Therapeutic Targeting
-
批准号:10436179
-
项目类别:
-
资助金额:$44.76万
-
财政年份:2018
-
负责人:SEBASTIAN JOYCE
-
依托单位:
Head & Neck Cancer Neoantigen Characterization & Therapeutic Targeting
-
批准号:10180937
-
项目类别:
-
资助金额:$45.54万
-
财政年份:2018
-
负责人:SEBASTIAN JOYCE
-
依托单位:
Vaccinating at Mucosal Surfaces with Nanoparticle Conjugated Antigen and Adjuvant
-
批准号:8974276
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:SEBASTIAN JOYCE
-
依托单位:
Processing and Presentation of Minor Histocompatibility Antigens that Cause GvHD
-
批准号:9269291
-
项目类别:
-
资助金额:$39.5万
-
财政年份:2014
-
负责人:SEBASTIAN JOYCE
-
依托单位:
Vaccinating at Mucosal Surfaces with Nanoparticle Conjugated Antigen and Adjuvant
-
批准号:8822136
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:SEBASTIAN JOYCE
-
依托单位:
Vaccinating at Mucosal Surfaces with Nanoparticle Conjugated Antigen and Adjuvant
-
批准号:10265410
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:SEBASTIAN JOYCE
-
依托单位:
Processing and Presentation of Minor Histocompatibility Antigens that Cause GvHD
-
批准号:8614968
-
项目类别:
-
资助金额:$39.21万
-
财政年份:2014
-
负责人:SEBASTIAN JOYCE
-
依托单位:
Vaccinating at Mucosal Surfaces with Nanoparticle Conjugated Antigen and Adjuvant
-
批准号:8633616
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:SEBASTIAN JOYCE
-
依托单位:
Processing and Presentation of Minor Histocompatibility Antigens that Cause GvHD
-
批准号:9250188
-
项目类别:
-
资助金额:$39.5万
-
财政年份:2014
-
负责人:SEBASTIAN JOYCE
-
依托单位:
Vaccinating at Mucosal Surfaces with Nanoparticle Conjugated Antigen and Adjuvant
-
批准号:9898281
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:SEBASTIAN JOYCE
-
依托单位:
Vaccinating at Mucosal Surfaces with Nanoparticle Conjugated Antigen and Adjuvant
-
批准号:9750508
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:SEBASTIAN JOYCE
-
依托单位:
Vaccinating at Mucosal Surfaces with Nanoparticle Conjugated Antigen and Adjuvant
-
批准号:10612330
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:SEBASTIAN JOYCE
-
依托单位:
国内基金
海外基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
-
批准号:2022J011295
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:王亚伟
-
依托单位:
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究
-
批准号:30801055
-
项目类别:青年科学基金项目
-
资助金额:19.0万元
-
批准年份:2008
-
负责人:王丽梅
-
依托单位: